Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

NCT05737121 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Interstitial Cystitis
Bladder Pain Syndrome

Interventions

DRUG: VNX001
DRUG: Placebo
DRUG: Lidocaine
DRUG: Heparin

Sponsor

Vaneltix Pharma, Inc.

Collaborators

[object Object]